Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism SPTBN1 inhibitors(spectrin beta, non-erythrocytic 1 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatocellular Carcinoma | Preclinical | United States | - | |
| Metabolic dysfunction-associated steatotic liver disease | Preclinical | United States | - | |
| Obesity | Preclinical | United States | - | |
| Nonalcoholic Steatohepatitis | Discovery | United States | 22 Aug 2024 |





